• Something wrong with this record ?

Laryngopharyngeal Reflux Is a Potential Risk Factor for Juvenile-Onset Recurrent Respiratory Papillomatosis

M. Formánek, P. Komínek, D. Jančatová, L. Staníková, R. Tomanová, J. Vaculová, M. Urík, I. Šlapák, K. Zeleník,

. 2019 ; 2019 (-) : 1463896. [pub] 20190210

Language English Country United States

Document type Journal Article

Introduction: Human papillomavirus (HPV) causes juvenile-onset recurrent respiratory papillomatosis (JORRP). Although HPV is common in children, the prevalence of JORRP is low. It is likely that other factors contribute to the pathogenesis of JORRP, during either activation or reactivation of a latent HPV infection. There is evidence that laryngopharyngeal reflux (LPR) might be such a risk factor for adult-onset recurrent respiratory papillomatosis. This study investigated if LPR might also be a risk factor for JORRP. Materials and Methods: Children with JORRP of the larynx that required microlaryngoscopy at a tertiary referral hospital were included in this prospective case-series study from November 2015 to November 2017. Using immunohistochemistry, HPV infection and pepsin associated with LPR were diagnosed from laryngeal biopsies. Results: Eleven children (aged 4-14 years) were analyzed. No patient had a history of immunodeficiency or tobacco smoke exposure. All patients underwent at least three previous surgeries due to JORRP and had been vaccinated against HPV in the past. Five children were treated using antivirotics and immunomodulators. The only known maternal risk factor was that three mothers were primiparous. All 11 samples were infected with HPV (type 6 or 11). Pathologic LPR was diagnosed in 5/11 children (45.5%). Conclusion: LPR may be a risk factor for JORRP, contributing to its development by activating or reactivating a latent HPV infection. Results are in accordance with those from our previous study in adults.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034705
003      
CZ-PrNML
005      
20191010120916.0
007      
ta
008      
191007s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2019/1463896 $2 doi
035    __
$a (PubMed)30881982
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Formánek, Martin $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 17. Listopadu 1790, 70852 Ostrava, Czech Republic.
245    10
$a Laryngopharyngeal Reflux Is a Potential Risk Factor for Juvenile-Onset Recurrent Respiratory Papillomatosis / $c M. Formánek, P. Komínek, D. Jančatová, L. Staníková, R. Tomanová, J. Vaculová, M. Urík, I. Šlapák, K. Zeleník,
520    9_
$a Introduction: Human papillomavirus (HPV) causes juvenile-onset recurrent respiratory papillomatosis (JORRP). Although HPV is common in children, the prevalence of JORRP is low. It is likely that other factors contribute to the pathogenesis of JORRP, during either activation or reactivation of a latent HPV infection. There is evidence that laryngopharyngeal reflux (LPR) might be such a risk factor for adult-onset recurrent respiratory papillomatosis. This study investigated if LPR might also be a risk factor for JORRP. Materials and Methods: Children with JORRP of the larynx that required microlaryngoscopy at a tertiary referral hospital were included in this prospective case-series study from November 2015 to November 2017. Using immunohistochemistry, HPV infection and pepsin associated with LPR were diagnosed from laryngeal biopsies. Results: Eleven children (aged 4-14 years) were analyzed. No patient had a history of immunodeficiency or tobacco smoke exposure. All patients underwent at least three previous surgeries due to JORRP and had been vaccinated against HPV in the past. Five children were treated using antivirotics and immunomodulators. The only known maternal risk factor was that three mothers were primiparous. All 11 samples were infected with HPV (type 6 or 11). Pathologic LPR was diagnosed in 5/11 children (45.5%). Conclusion: LPR may be a risk factor for JORRP, contributing to its development by activating or reactivating a latent HPV infection. Results are in accordance with those from our previous study in adults.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a biopsie $7 D001706
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hypofarynx $x patofyziologie $x virologie $7 D007013
650    _2
$a laryngofaryngeální reflux $x patofyziologie $x virologie $7 D057045
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a Papillomaviridae $x patogenita $7 D027383
650    _2
$a infekce papilomavirem $x patofyziologie $x virologie $7 D030361
650    _2
$a infekce dýchací soustavy $x patofyziologie $x virologie $7 D012141
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
700    1_
$a Komínek, Pavel $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 17. Listopadu 1790, 70852 Ostrava, Czech Republic.
700    1_
$a Jančatová, Debora $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 17. Listopadu 1790, 70852 Ostrava, Czech Republic.
700    1_
$a Staníková, Lucia $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 17. Listopadu 1790, 70852 Ostrava, Czech Republic.
700    1_
$a Tomanová, Radoslava $u Department of Pathology, University Hospital Ostrava, 17. Listopadu 1790, 70852 Ostrava, Czech Republic.
700    1_
$a Vaculová, Jana $u Department of Pathology, University Hospital Ostrava, 17. Listopadu 1790, 70852 Ostrava, Czech Republic.
700    1_
$a Urík, Milan $u Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
700    1_
$a Šlapák, Ivo $u Faculty of Medicine, Masaryk University, Kamenice 5, 625 00 Brno, Czech Republic.
700    1_
$a Zeleník, Karol $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Ostrava, 17. Listopadu 1790, 70852 Ostrava, Czech Republic.
773    0_
$w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2019, č. - (2019), s. 1463896
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30881982 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191010121335 $b ABA008
999    __
$a ok $b bmc $g 1451365 $s 1073255
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 2019 $c - $d 1463896 $e 20190210 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...